Analysts expect Axsome Therapeutics, Inc. to report revenue of 297.55 M for Q4 26, against a range of 287.51 M to 307.59 M. The most recent reported quarter, Q3 26, came in at 259.69 M, a 9.8% beat against the 236.50 M consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 118.77 M | 121.46 M | 150.04 M | 170.99 M | 196.00 M | 191.20 M | 218.38 M | 259.69 M | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 129.80 M | 119.52 M | 140.62 M | 183.88 M | 195.48 M | 209.92 M | 244.34 M | 249.38 M | 307.59 M | 306.22 M | 396.57 M | 398.82 M | 429.96 M | 502.63 M | 501.97 M | 565.73 M | |||||||||
| Low Estimate | 115.51 M | 108.34 M | 119.58 M | 159.81 M | 165.93 M | 183.57 M | 220.34 M | 223.61 M | 287.51 M | 275.41 M | 329.44 M | 331.91 M | 359.14 M | 434.16 M | 427.55 M | 477.01 M | |||||||||
| Consensus Estimate | 122.65 M | 113.93 M | 130.10 M | 171.84 M | 180.70 M | 196.74 M | 232.34 M | 236.50 M | 297.55 M | 290.81 M | 363.00 M | 365.37 M | 394.55 M | 468.40 M | 464.76 M | 521.37 M |
Analysts expect Axsome Therapeutics, Inc. to report earnings per share of -0.08 for Q4 26, against a range of -0.09 to -0.07. The most recent reported quarter, Q3 26, came in at -0.25, a 57.6% beat against the -0.59 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -1.54 | -1.22 | -0.97 | -0.94 | -0.56 | -1.26 | -0.99 | -0.25 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | -0.90 | -1.18 | -1.06 | -0.76 | -0.62 | -0.83 | -0.78 | -0.55 | -0.07 | 0.07 | 0.69 | 1.20 | 1.46 | 1.89 | 2.32 | 3.08 | |||||||||
| Low Estimate | -0.98 | -1.40 | -1.16 | -0.84 | -0.68 | -0.91 | -0.94 | -0.63 | -0.09 | 0.07 | 0.61 | 1.00 | 1.24 | 1.65 | 2.10 | 2.54 | |||||||||
| Consensus Estimate | -0.94 | -1.29 | -1.11 | -0.80 | -0.65 | -0.87 | -0.86 | -0.59 | -0.08 | 0.07 | 0.65 | 1.10 | 1.35 | 1.77 | 2.21 | 2.81 |
Pull Wall Street consensus for Axsome Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=AXSM&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "AXSM", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=AXSM&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();